SK Life Science will also host the "Prioritizing Seizure Treatments Through Real-World Patient Case Studies Symposium," an expert led panel to advance the discussion regarding the unmet need for ...

"Road to Reduction" Begins Airing Today Raising Awareness of XCOPRI® (cenobamate tablets) CV and the Journey to Seizure Management for People Living with Epilepsy PARAMUS, N.J., May 19, 2025 ...

It’s boots on the ground, or rather in the office, for SK Life Science’s latest sales push aimed at getting its target, i.e., neurologists, to pay attention. The unconventional approach of “The Shoe ...

KING OF PRUSSIA, Pa., Feb. 08, 2024 (GLOBE NEWSWIRE) -- SK Life Science Labs (formerly Proteovant Therapeutics) a subsidiary of SK Biopharmaceuticals, Co., Ltd., showcased its cutting-edge targeted ...

KING OF PRUSSIA, Pa., March 21, 2024 (GLOBE NEWSWIRE) -- SK Life Science Labs, a subsidiary of SK Biopharmaceuticals, Co., Ltd., a global biotech focused on the research, development, and ...

SK Life Science is encouraging patients beetling down the long and winding road toward seizure-free life to switch gears. In a new nationwide direct-to-consumer (DTC) ad, the Xcopri manufacturer asks ...

KING OF PRUSSIA, Pa., May 1, 2025 /PRNewswire/ -- SK Life Science Labs, a subsidiary of SK Biopharmaceuticals Co., Ltd., a global biotech focused on the research, development, and commercialization of ...

SK Bioscience CEO Ahn Jae-yong, left, and Sanofi's Jean-Francois Toussant, global head of vaccine research and development, pose for the photo after a signing ceremony. [SK BIOSCIENCE] SK bioscience ...

SK bioscience said on the 9th that it introduced the quadrivalent meningococcal conjugate vaccine "MenQuadfi" in Korea in cooperation with Sanofi Korea. The vaccine can be given from 6 weeks of age ...

Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research outputs may not equal the overall research outputs. Identify research insights to guide ...